Purpose This study aimed to conduct a multivariate analysis to identify independent factors that predict tibial tunnel widening (TW) after anatomical anterior cruciate ligament (ACL) reconstruction using bone-patellar tendon-bone (BPTB) grafts. Methods In total, 103 patients who underwent ACL reconstructions using BPTB grafts were included. Tunnel aperture area was measured using three-dimensional computed tomography 1 week and 1 year postoperatively, and the tibial TW was calculated. The patients were divided into group S comprising 58 patients who had tibial TW < 30% and group L comprising 45 patients who had tibial TW > 30%, retrospectively. Using univariate analyses, age, gender, body mass index, Tegner activity scale, the time between injury and surgery, tibial tunnel location, tibial tunnel angle, medial posterior tibial slope, lateral posterior tibial slope, and length of the tendon in the tibial tunnel were compared between two groups. Multivariate regression analysis was conducted to reveal the independent risk factors for the tibial TW among preoperative demographic factors and radiographic parameters that correlated with the tibial TW in the univariate analyses. Results Compared with those at 1 week postoperatively, mean tibial tunnel aperture areas were increased by 30.3% ± 26.8% when measured at 1 year postoperatively. The lateral posterior tibial slope was signiicantly larger (p < 0.001), and the length of the tendon within the tibial tunnel was signiicantly longer in group L than that in group S (p = 0.03) in the univariate analyses. Multivariate regression analysis showed that the increase in lateral posterior tibial slope (p = 0.001) and the length of the tendon within the tibial tunnel (p = 0.03) were predictors of the tibial TW. Conclusions This study showed that increased lateral posterior tibial slope and a longer tendinous portion within the tibial tunnel were independent factors that predicted the tibial TW following anatomical ACL reconstruction with a BPTB graft. Level of evidence III.
The purpose of this study was to retrospectively investigate the effects of variations in the length of the tendon within the tibial tunnel on tunnel widening (TW) following anatomical anterior cruciate ligament (ACL) reconstruction using a bone–patellar tendon–bone (BTB) graft. In total, 68 patients who underwent isolated ACL reconstructions using BTB grafts were included in this study. The patients were divided into two groups according to the length of the tendon within the tibial tunnel: group S (n = 30; tendon length, < 10 mm) and group L (n = 38; tendon length, ≥ 10 mm). Tunnel aperture area was measured using three-dimensional computed tomography (3D CT) at 1 week and 1 year postoperatively, and tibial TW (%) was calculated. The correlation coefficient between the length of the tendon within the tibial tunnel and tibial TW was also calculated. Clinical assessment was performed 1 year postoperatively, corresponding to the period of CT assessment, which involved the evaluation of the Lysholm's score, measurement of anterior knee stability using a KneeLax3 arthrometer, and the pivot-shift test. A weak positive correlation was observed between the length of the tendon within the tibial tunnel and tibial TW (r = 0.270, p = 0.026). Mean tibial tunnel aperture area increased by 19.3 ± 17.4% and 35.8 ± 25.4% in the groups S and L, respectively. TW in the group L was significantly greater than that in the group S (p = 0.004). No significant difference was observed between the two groups in any clinical outcomes. In conclusion, a longer tendinous portion within the tibial tunnel resulted in a greater tibial TW following anatomical ACL reconstructions using a BTB graft.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.